FDA warns on antipsychotic use in pregnancy; NICE blesses GSK cancer med Votrient;

@FiercePharma: M&A fills patent holes, fuels geographic expansion. Report | Follow @FiercePharma

> The anti-addiction drug Antabuse will be tested in HIV-infected patients as a potential weapon against the reservoirs of virus that remain even after treatment with AIDS drugs. Story

> The FDA issued a safety alert about the risks to newborns of exposure to nearly two dozen antipsychotics during pregnancy. Article

> NICE has recommended GlaxoSmithKline's kidney cancer drug Votrient on the same day it gave a final negative decision to Roche's Avastin in breast cancer. Report

> Eisai said the Japan Intellectual Property High Court ruled in favor of extending its patent for the Alzheimer's drug Aricept until June 2013. News

> Detroit's Caraco Pharmaceutical has agreed to merge with India-based majority owner Sun Pharmaceutical Industries. Item

> The federal government is questioning whether our neighbors to the north will be looking out for the U.S. taxpayers in a Canadian pharmaceutical company's insolvency case. News

Biotech News

@FierceBiotech: FDA chief vows fast delivery of new biosimilar rules. Report | Follow @FierceBiotech

@JohnCFierce: So, how about it scribes? Is Vertex the smartest drug developer out there? | Follow @JohnCFierce 

> Gilead's Calistoga buyout marks effort to make cancer a chronic condition. Article

> PPD steps in as Elan's go-to CRO for development work. Item

> Vertex dazzles analysts with landmark Ph3 CF results. News

Drug Delivery News

> FluGen lands $7.8M for microneedle vaccine delivery patch. News

> MIT tests new nanoparticle for vaccine delivery. Report

> MannKind job cuts hit CT site after FDA rejects inhaled insulin. Report

> Boston Scientific charts stent growth in India. Story

> Versartis grabs $21M Series B, aims to begin study of once-monthly hormone therapy. Article

Medical Device News

> Devicemakers explore pacemakers for psychiatric disease. Story

> FDA device approval: Too fast or too slow? Report

> Amendia expands as it raises cash. Article

> gets FDA OK for dialysis machine. News

> J&J recalls 400 arthritis treatment pens. Report

And Finally... A study shows that bisphosphonate drugs do reduce the risk of typical fractures caused by osteoporosis, but may also increase the risk of other, "atypical" fractures. Report